Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3

Journal:

The New England Journal of Medicine

Published:

2025-11-09

DOI:

10.1056/nejmoa2511778

Affiliations:

7

Authors:

14

Go to article

Institutions	Authors	Share
Cleveland Clinic, United States of America (USA)	5.000000	0.36
CRISPR Therapeutics, Inc., United States of America (USA)	5.000000	0.36
Aotearoa Clinical Trials, New Zealand	1.000000	0.07
Monash University, Australia	1.000000	0.07
New Zealand Clinical Research (NZCR), New Zealand	1.000000	0.07
Royal Adelaide Hospital (RAH), Australia	1.000000	0.07

Interested in Cardiovascular Medicine and Haematology?